Please note: This website has recently moved from www.health.gov to odphp.health.gov. www.health.gov is now the official website of ODPHP’s parent organization, the Office of the Assistant Secretary for Health (OASH). Please update your bookmarks for easy access to all our resources. 

Increase the proportion of adults with serious mental illness who get treatment — MHMD‑04 Data Methodology and Measurement

About the National Data

Data

Baseline: 66.7 percent of adults aged 18 years and over with SMI received treatment in 2022

Target: 71.3 percent

Numerator
Number of adults aged 18 years and over with SMI who received treatment.
Denominator
Number of adults aged 18 years and over with SMI.
Target-setting method
Percentage point improvement
Target-setting method details
Percentage point improvement from the baseline using Cohen's h effect size of 0.10.
1
Target-setting method justification
Trend data were not evaluated for this objective, but it was not possible to project a target because the trend analysis could not find a suitable target. A percentage point improvement was calculated using Cohen's h effect size of 0.1. This method was used because the Healthy People 2030 Workgroup Subject Matter Experts viewed this as an ambitious yet achievable target. The 21st Century Cures Act calls for an increase in evidence-based resources to improve access to evidence-based interventions.

Methodology

Questions used to obtain the national baseline data

(For additional information, please visit the data source page linked above.)

Please refer to the “Adolescent Depression” module of the “2021 National Survey on Drug Use and Health (NSDUH): Final CAI Specifications for Programming” for baseline questions.

Methodology notes

Serious mental illness (SMI) among adults was defined in Public Law 102-321 as adults aged 18 or older who currently or at any time in the past year have had a diagnosable mental, behavioral, or emotional disorder and resulting in substantial impairment in carrying out major life activities. In NSDUH, a diagnosable mental, behavioral, or emotional disorder was defined as for the other mental illness categories described previously (i.e., based on the Diagnostic and Statistical Manual of Mental Disorders, 4th edition [DSM-IV] and excluding developmental and substance use disorders); substantial impairment was defined based on clinical interview Global Assessment of Functioning scores of 50 or below. SMI was estimated based on a statistical model of a clinical diagnosis and responses to questions in the main NSDUH interview on distress (Kessler-6 scale), impairment (truncated version of the World Health Organization Disability Assessment Schedule), past year major depressive episode, past year suicidal thoughts, and age. All adults with SMI were also classified as having any mental illness (AMI).


Mental health treatment in the past year was defined as the receipt of treatment or counseling for any problem with mental health, emotions, or behavior in the 12 months prior to the interview. Respondents were asked in the mental health services utilization section of the questionnaire to report whether they received mental health treatment in the past 12 months in an inpatient location, in an outpatient location, through the use of prescription medication, via telehealth treatment, or in a prison, jail, or juvenile detention center.

History

Comparable HP2020 objective
Modified, which includes core objectives that are continuing from HP2020 but underwent a change in measurement.
Changes between HP2020 and HP2030
The National Survey on Drug Use and Health adopted a multimode data collection method in 2021. Due to this change, data starting in 2021 are not comparable to those from earlier years. Additionally, the mental health treatment questions on the National Survey on Drug Use and Health underwent considerable revisions in the 2022 survey. Due to these changes, the 2022 estimates for mental health treatment cannot be compared with estimates from 2021 or earlier years.
Revision History
Revised. 

In 2024, due to the NSDUH adopting a multimode data collection method in 2021 and due to considerable revisions made to the mental health treatment questions on the 2022 survey, the baseline was revised from 64.1% in 2018 to 66.7% in 2022. The target was revised from 68.8% to 71.3% using the original target setting method.


1. Effect size h=0.1 was chosen to correspond with 10% improvement from a baseline of 50%.